November 9, 2016

Jonathan E. Becker, D.O., Assistant Professor of Clinical Psychiatry and Behavioral Sciences," served as lead author for the paper "Update on Transcranial Magnetic Stimulation for Depression and Other Neuropsychiatric Illnesses" in the publication Psychiatric Annals. Transcranial magnetic stimulation (TMS) is a neuromodulation technique that was first approved for the treatment of major depressive disorder in 2008. Because of the success of TMS in treating depression, there has been interest in applications for other neuropsychiatric diseases. During the last several years, research has grown on the use of TMS for obsessive-compulsive disorder, schizophrenia, substance use disorders, anxiety disorders, posttraumatic stress disorder, Parkinson's disease, and chronic pain. This article provides a brief background of the current use of TMS in clinical practice and reviews the current data on the use of TMS in the treatment of depression and other neuropsychiatric disorders.

Click here to view the article.